chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Impaired work ability, Insomnia, Loss of personal independence in daily activities, Myalgia
Clinical narrative: Had COVID 17 Dec 2020    Recovered Had vaccination shot 6 Oct 2021 By 1am on the 7 Oct had severe symptoms - chills, muscle aches, headache, sweats, fatigue, tiredness and inability to sleep.   Way more severe than when I had COVID  Started taking Advil by end of day on the 8th. Most severe symptoms subsided by the end of day on the 11th. Sweats and chills continued until the 16th.   Persistent headache, fatigue and tiredness since the shot. Headache pronounced from early morning until waking up from afternoon nap. Fatigue and tiredness very severe to the point that I can't work or function after 3-4pm every day.   Since the  18th I have been a zombie on the couch from 3 to 4or5 pm  for several days trying to fight to stay awake. By the 10th finally giving up and taking a nap from 4 to 6or7pm every day. Tired to the point that I can't even leave the house and would not think of driving in the late afternoon.  Fatigue since the shot has left me unable to exercise more than a hour of a walk or mild housework.  Had none of this headache, tiredness, fatigue in the aftermath of COVID.  I feel debilitated in a way I have never experienced.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: 06/22/2021- bumps on the back of my head. They spread rapidly to my jaw line, shoulder, and neck all on the right side. 06/28/2021- I went into an urgent care, walk-in clinic- they told me it was poison ivy and they put me on Prednisone. It was not getting better it was getting worse. I went back to the clinic on 06/30/2021. They said the same thing, poison ivy, and they increased the Prednisone. Still was not getting better, so I called. And she did a zoom call and diagnosed me as shingles. and put me on a shingles  medicine. I started feeling better about 2 weeks later. The lesions were gone within  6 to 8 weeks later. It took a long time. After that I got both Shingles vaccinations- 1st dose 08/05/2021 and 2nd dose was 10/06/2021.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Fibrin D dimer, Pulmonary embolism, Ultrasound scan
Clinical narrative: Bilateral pulmonary embolism
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Acute kidney injury, Angiogram pulmonary abnormal, Anticoagulant therapy, Aspiration pleural cavity
Clinical narrative: Hospitalized 10/17/2021; COVID-19 positive 10/17/2021; fully vaccinated  Discharge Summary  DO (Physician) ? ? General Medicine Discharge Summary   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: PA  Admission Date: 10/17/2021 Discharge Date: 10/21/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 67-year-old female with history of COPD, type 2 diabetes mellitus, paroxysmal atrial fibrillation on Coumadin, hypertension, peripheral vascular disease and mitral stenosis who presented with abdominal pain, nausea with vomiting, and chills.  She had diffuse abdominal pain on exam.  Work-up in the ED included CT abdomen/pelvis, which showed no acute findings to explain her presenting symptoms.  Labs revealed INR of 2.8, lactic acid 6.2, WBC count 11.8, potassium 3.3, Cr 1.16.  COVID testing was done in the ED, and returned positive.  Chest x-ray was done, and mild residual infiltrates in both lung bases.  She was given 40 mEq of potassium in the ED, and was transferred from ED to Hospital for admission. Upon admission, she was continued on oxygen at 2 Lpm.  For COVID pneumonia, she was started on Decadron 6 mg daily.  She was treated with anti-tussives and prn Albuterol inhaler.  With supportive treatment, her lactic acid was trended, and trended down.  We were not able to wean her back to room air (she was previously using oxygen only as needed), and she will be discharged with 2 L oxygen at all times.  She will be discharged on 6 mg of Decadron daily for 5 more days. Due to evidence of AKI on presentation, her diuretics were held.  Cr trended down, and was back to baseline, so diuretics were resumed on 10/20, which she tolerated well. Her INR was therapeutic at 2.8 on admission, but did rise to 6.9 by 10/19/21.  Her COumadin was held at that time, and INR drifted back down to 4.1 by time of hospital discharge.  Patient was instructed to hold Coumadin doses on 10/21 and 10/22, and will take 2.5 mg daily on 10/23 and 10/24.  She will have an INR level checked on 10/25, with results/further instructions to be reviewed by anticoagulation clinic.  I did call and speak with anticoagulation clinic nurse today, and made them aware of these recommendations. She was felt stable for discharge home on 10/21/21.  She will be discharged home on 5 more days of Decadron.  She should follow-up with PA in 1 week.  She will hold Coumadin on 10/21 and 10/22, and will take 2.5 mg of Coumadin on 10/23 and 10/24, with a follow-up INR to be drawn on 10/25.  Anticoagulation clinic to follow-up on results and make recommendations from there.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Blood creatinine increased, Blood lactic acid, Blood potassium decreased, Brain natriuretic peptide increased
Clinical narrative: Hospitalized 10/17/2021; COVID-19 positive 10/17/2021; fully vaccinated  Discharge Summary  DO (Physician) ? ? General Medicine Discharge Summary   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: PA  Admission Date: 10/17/2021 Discharge Date: 10/21/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 67-year-old female with history of COPD, type 2 diabetes mellitus, paroxysmal atrial fibrillation on Coumadin, hypertension, peripheral vascular disease and mitral stenosis who presented with abdominal pain, nausea with vomiting, and chills.  She had diffuse abdominal pain on exam.  Work-up in the ED included CT abdomen/pelvis, which showed no acute findings to explain her presenting symptoms.  Labs revealed INR of 2.8, lactic acid 6.2, WBC count 11.8, potassium 3.3, Cr 1.16.  COVID testing was done in the ED, and returned positive.  Chest x-ray was done, and mild residual infiltrates in both lung bases.  She was given 40 mEq of potassium in the ED, and was transferred from ED to Hospital for admission. Upon admission, she was continued on oxygen at 2 Lpm.  For COVID pneumonia, she was started on Decadron 6 mg daily.  She was treated with anti-tussives and prn Albuterol inhaler.  With supportive treatment, her lactic acid was trended, and trended down.  We were not able to wean her back to room air (she was previously using oxygen only as needed), and she will be discharged with 2 L oxygen at all times.  She will be discharged on 6 mg of Decadron daily for 5 more days. Due to evidence of AKI on presentation, her diuretics were held.  Cr trended down, and was back to baseline, so diuretics were resumed on 10/20, which she tolerated well. Her INR was therapeutic at 2.8 on admission, but did rise to 6.9 by 10/19/21.  Her COumadin was held at that time, and INR drifted back down to 4.1 by time of hospital discharge.  Patient was instructed to hold Coumadin doses on 10/21 and 10/22, and will take 2.5 mg daily on 10/23 and 10/24.  She will have an INR level checked on 10/25, with results/further instructions to be reviewed by anticoagulation clinic.  I did call and speak with anticoagulation clinic nurse today, and made them aware of these recommendations. She was felt stable for discharge home on 10/21/21.  She will be discharged home on 5 more days of Decadron.  She should follow-up with PA in 1 week.  She will hold Coumadin on 10/21 and 10/22, and will take 2.5 mg of Coumadin on 10/23 and 10/24, with a follow-up INR to be drawn on 10/25.  Anticoagulation clinic to follow-up on results and make recommendations from there.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cardiac failure congestive, Chest X-ray abnormal, Chest pain
Clinical narrative: Hospitalized 10/17/2021; COVID-19 positive 10/17/2021; fully vaccinated  Discharge Summary  DO (Physician) ? ? General Medicine Discharge Summary   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: PA  Admission Date: 10/17/2021 Discharge Date: 10/21/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 67-year-old female with history of COPD, type 2 diabetes mellitus, paroxysmal atrial fibrillation on Coumadin, hypertension, peripheral vascular disease and mitral stenosis who presented with abdominal pain, nausea with vomiting, and chills.  She had diffuse abdominal pain on exam.  Work-up in the ED included CT abdomen/pelvis, which showed no acute findings to explain her presenting symptoms.  Labs revealed INR of 2.8, lactic acid 6.2, WBC count 11.8, potassium 3.3, Cr 1.16.  COVID testing was done in the ED, and returned positive.  Chest x-ray was done, and mild residual infiltrates in both lung bases.  She was given 40 mEq of potassium in the ED, and was transferred from ED to Hospital for admission. Upon admission, she was continued on oxygen at 2 Lpm.  For COVID pneumonia, she was started on Decadron 6 mg daily.  She was treated with anti-tussives and prn Albuterol inhaler.  With supportive treatment, her lactic acid was trended, and trended down.  We were not able to wean her back to room air (she was previously using oxygen only as needed), and she will be discharged with 2 L oxygen at all times.  She will be discharged on 6 mg of Decadron daily for 5 more days. Due to evidence of AKI on presentation, her diuretics were held.  Cr trended down, and was back to baseline, so diuretics were resumed on 10/20, which she tolerated well. Her INR was therapeutic at 2.8 on admission, but did rise to 6.9 by 10/19/21.  Her COumadin was held at that time, and INR drifted back down to 4.1 by time of hospital discharge.  Patient was instructed to hold Coumadin doses on 10/21 and 10/22, and will take 2.5 mg daily on 10/23 and 10/24.  She will have an INR level checked on 10/25, with results/further instructions to be reviewed by anticoagulation clinic.  I did call and speak with anticoagulation clinic nurse today, and made them aware of these recommendations. She was felt stable for discharge home on 10/21/21.  She will be discharged home on 5 more days of Decadron.  She should follow-up with PA in 1 week.  She will hold Coumadin on 10/21 and 10/22, and will take 2.5 mg of Coumadin on 10/23 and 10/24, with a follow-up INR to be drawn on 10/25.  Anticoagulation clinic to follow-up on results and make recommendations from there.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Computerised tomogram abdomen normal, Condition aggravated, Dyspnoea, Electrocardiogram abnormal
Clinical narrative: Hospitalized 10/17/2021; COVID-19 positive 10/17/2021; fully vaccinated  Discharge Summary  DO (Physician) ? ? General Medicine Discharge Summary   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: PA  Admission Date: 10/17/2021 Discharge Date: 10/21/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 67-year-old female with history of COPD, type 2 diabetes mellitus, paroxysmal atrial fibrillation on Coumadin, hypertension, peripheral vascular disease and mitral stenosis who presented with abdominal pain, nausea with vomiting, and chills.  She had diffuse abdominal pain on exam.  Work-up in the ED included CT abdomen/pelvis, which showed no acute findings to explain her presenting symptoms.  Labs revealed INR of 2.8, lactic acid 6.2, WBC count 11.8, potassium 3.3, Cr 1.16.  COVID testing was done in the ED, and returned positive.  Chest x-ray was done, and mild residual infiltrates in both lung bases.  She was given 40 mEq of potassium in the ED, and was transferred from ED to Hospital for admission. Upon admission, she was continued on oxygen at 2 Lpm.  For COVID pneumonia, she was started on Decadron 6 mg daily.  She was treated with anti-tussives and prn Albuterol inhaler.  With supportive treatment, her lactic acid was trended, and trended down.  We were not able to wean her back to room air (she was previously using oxygen only as needed), and she will be discharged with 2 L oxygen at all times.  She will be discharged on 6 mg of Decadron daily for 5 more days. Due to evidence of AKI on presentation, her diuretics were held.  Cr trended down, and was back to baseline, so diuretics were resumed on 10/20, which she tolerated well. Her INR was therapeutic at 2.8 on admission, but did rise to 6.9 by 10/19/21.  Her COumadin was held at that time, and INR drifted back down to 4.1 by time of hospital discharge.  Patient was instructed to hold Coumadin doses on 10/21 and 10/22, and will take 2.5 mg daily on 10/23 and 10/24.  She will have an INR level checked on 10/25, with results/further instructions to be reviewed by anticoagulation clinic.  I did call and speak with anticoagulation clinic nurse today, and made them aware of these recommendations. She was felt stable for discharge home on 10/21/21.  She will be discharged home on 5 more days of Decadron.  She should follow-up with PA in 1 week.  She will hold Coumadin on 10/21 and 10/22, and will take 2.5 mg of Coumadin on 10/23 and 10/24, with a follow-up INR to be drawn on 10/25.  Anticoagulation clinic to follow-up on results and make recommendations from there.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: International normalised ratio increased, Leukocytosis, Lung infiltration, Nausea, Pleural effusion
Clinical narrative: Hospitalized 10/17/2021; COVID-19 positive 10/17/2021; fully vaccinated  Discharge Summary  DO (Physician) ? ? General Medicine Discharge Summary   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: PA  Admission Date: 10/17/2021 Discharge Date: 10/21/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 67-year-old female with history of COPD, type 2 diabetes mellitus, paroxysmal atrial fibrillation on Coumadin, hypertension, peripheral vascular disease and mitral stenosis who presented with abdominal pain, nausea with vomiting, and chills.  She had diffuse abdominal pain on exam.  Work-up in the ED included CT abdomen/pelvis, which showed no acute findings to explain her presenting symptoms.  Labs revealed INR of 2.8, lactic acid 6.2, WBC count 11.8, potassium 3.3, Cr 1.16.  COVID testing was done in the ED, and returned positive.  Chest x-ray was done, and mild residual infiltrates in both lung bases.  She was given 40 mEq of potassium in the ED, and was transferred from ED to Hospital for admission. Upon admission, she was continued on oxygen at 2 Lpm.  For COVID pneumonia, she was started on Decadron 6 mg daily.  She was treated with anti-tussives and prn Albuterol inhaler.  With supportive treatment, her lactic acid was trended, and trended down.  We were not able to wean her back to room air (she was previously using oxygen only as needed), and she will be discharged with 2 L oxygen at all times.  She will be discharged on 6 mg of Decadron daily for 5 more days. Due to evidence of AKI on presentation, her diuretics were held.  Cr trended down, and was back to baseline, so diuretics were resumed on 10/20, which she tolerated well. Her INR was therapeutic at 2.8 on admission, but did rise to 6.9 by 10/19/21.  Her COumadin was held at that time, and INR drifted back down to 4.1 by time of hospital discharge.  Patient was instructed to hold Coumadin doses on 10/21 and 10/22, and will take 2.5 mg daily on 10/23 and 10/24.  She will have an INR level checked on 10/25, with results/further instructions to be reviewed by anticoagulation clinic.  I did call and speak with anticoagulation clinic nurse today, and made them aware of these recommendations. She was felt stable for discharge home on 10/21/21.  She will be discharged home on 5 more days of Decadron.  She should follow-up with PA in 1 week.  She will hold Coumadin on 10/21 and 10/22, and will take 2.5 mg of Coumadin on 10/23 and 10/24, with a follow-up INR to be drawn on 10/25.  Anticoagulation clinic to follow-up on results and make recommendations from there.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pleuritic pain, Polyuria, SARS-CoV-2 test positive, Troponin, Urine analysis normal
Clinical narrative: Hospitalized 10/17/2021; COVID-19 positive 10/17/2021; fully vaccinated  Discharge Summary  DO (Physician) ? ? General Medicine Discharge Summary   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: PA  Admission Date: 10/17/2021 Discharge Date: 10/21/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 67-year-old female with history of COPD, type 2 diabetes mellitus, paroxysmal atrial fibrillation on Coumadin, hypertension, peripheral vascular disease and mitral stenosis who presented with abdominal pain, nausea with vomiting, and chills.  She had diffuse abdominal pain on exam.  Work-up in the ED included CT abdomen/pelvis, which showed no acute findings to explain her presenting symptoms.  Labs revealed INR of 2.8, lactic acid 6.2, WBC count 11.8, potassium 3.3, Cr 1.16.  COVID testing was done in the ED, and returned positive.  Chest x-ray was done, and mild residual infiltrates in both lung bases.  She was given 40 mEq of potassium in the ED, and was transferred from ED to Hospital for admission. Upon admission, she was continued on oxygen at 2 Lpm.  For COVID pneumonia, she was started on Decadron 6 mg daily.  She was treated with anti-tussives and prn Albuterol inhaler.  With supportive treatment, her lactic acid was trended, and trended down.  We were not able to wean her back to room air (she was previously using oxygen only as needed), and she will be discharged with 2 L oxygen at all times.  She will be discharged on 6 mg of Decadron daily for 5 more days. Due to evidence of AKI on presentation, her diuretics were held.  Cr trended down, and was back to baseline, so diuretics were resumed on 10/20, which she tolerated well. Her INR was therapeutic at 2.8 on admission, but did rise to 6.9 by 10/19/21.  Her COumadin was held at that time, and INR drifted back down to 4.1 by time of hospital discharge.  Patient was instructed to hold Coumadin doses on 10/21 and 10/22, and will take 2.5 mg daily on 10/23 and 10/24.  She will have an INR level checked on 10/25, with results/further instructions to be reviewed by anticoagulation clinic.  I did call and speak with anticoagulation clinic nurse today, and made them aware of these recommendations. She was felt stable for discharge home on 10/21/21.  She will be discharged home on 5 more days of Decadron.  She should follow-up with PA in 1 week.  She will hold Coumadin on 10/21 and 10/22, and will take 2.5 mg of Coumadin on 10/23 and 10/24, with a follow-up INR to be drawn on 10/25.  Anticoagulation clinic to follow-up on results and make recommendations from there.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting, White blood cell count increased
Clinical narrative: Hospitalized 10/17/2021; COVID-19 positive 10/17/2021; fully vaccinated  Discharge Summary  DO (Physician) ? ? General Medicine Discharge Summary   BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider at Discharge: PA  Admission Date: 10/17/2021 Discharge Date: 10/21/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 67-year-old female with history of COPD, type 2 diabetes mellitus, paroxysmal atrial fibrillation on Coumadin, hypertension, peripheral vascular disease and mitral stenosis who presented with abdominal pain, nausea with vomiting, and chills.  She had diffuse abdominal pain on exam.  Work-up in the ED included CT abdomen/pelvis, which showed no acute findings to explain her presenting symptoms.  Labs revealed INR of 2.8, lactic acid 6.2, WBC count 11.8, potassium 3.3, Cr 1.16.  COVID testing was done in the ED, and returned positive.  Chest x-ray was done, and mild residual infiltrates in both lung bases.  She was given 40 mEq of potassium in the ED, and was transferred from ED to Hospital for admission. Upon admission, she was continued on oxygen at 2 Lpm.  For COVID pneumonia, she was started on Decadron 6 mg daily.  She was treated with anti-tussives and prn Albuterol inhaler.  With supportive treatment, her lactic acid was trended, and trended down.  We were not able to wean her back to room air (she was previously using oxygen only as needed), and she will be discharged with 2 L oxygen at all times.  She will be discharged on 6 mg of Decadron daily for 5 more days. Due to evidence of AKI on presentation, her diuretics were held.  Cr trended down, and was back to baseline, so diuretics were resumed on 10/20, which she tolerated well. Her INR was therapeutic at 2.8 on admission, but did rise to 6.9 by 10/19/21.  Her COumadin was held at that time, and INR drifted back down to 4.1 by time of hospital discharge.  Patient was instructed to hold Coumadin doses on 10/21 and 10/22, and will take 2.5 mg daily on 10/23 and 10/24.  She will have an INR level checked on 10/25, with results/further instructions to be reviewed by anticoagulation clinic.  I did call and speak with anticoagulation clinic nurse today, and made them aware of these recommendations. She was felt stable for discharge home on 10/21/21.  She will be discharged home on 5 more days of Decadron.  She should follow-up with PA in 1 week.  She will hold Coumadin on 10/21 and 10/22, and will take 2.5 mg of Coumadin on 10/23 and 10/24, with a follow-up INR to be drawn on 10/25.  Anticoagulation clinic to follow-up on results and make recommendations from there.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: pt was administered dose of vaccine that had been in the refrigerator longer than 6 hours, which is the longest per manufacturer guidelines.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Diarrhoea, Fatigue, Malaise
Clinical narrative: Abdominal distention, diarrhea, fatigue, malaise lasting 10 days
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Herpes zoster
Clinical narrative: fatigue, shingles
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Herpes zoster, Rash vesicular
Clinical narrative: Pain in eye within 36 hours or administration and then vesicular rash on day 3, with diagnosis of  Cranial Nerve 2 shingles.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was given a dose of Pfizer vaccine on 10/25/2021 however vial of Pfizer vaccine was reconstituted on 10/22/2021 @ 4:45pm. After 6 hours vial should have been discarded and not used. However vaccine was given in error.  No side effects noted from patient at this time
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Breast tenderness, C-reactive protein, Cyanosis, Erythema
Clinical narrative: Immediately that night I started having full nerve pain head to toe, not typical body aches. My lips went numb, I lost sensation in my hands and feet then it turned to pins and needles. Approx. 3 days after receiving the vaccination, it felt like I was walking on glass and my hands and feet would turn cyanotic off and on. Headaches and stiff neck. I ran fever for a week off and on, swelling, redness and heat to my Left upper extremity along with swelling of lymph nodes and breast to the left side. with extreme tenderness. My physician currently has me a Medrol dose pack to help with the pain to my arms, hands and feet. So far no changes.  The stiffness and headaches have slightly improved.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Full blood count, Headache, Hypoaesthesia oral, Lymphadenopathy, Musculoskeletal stiffness
Clinical narrative: Immediately that night I started having full nerve pain head to toe, not typical body aches. My lips went numb, I lost sensation in my hands and feet then it turned to pins and needles. Approx. 3 days after receiving the vaccination, it felt like I was walking on glass and my hands and feet would turn cyanotic off and on. Headaches and stiff neck. I ran fever for a week off and on, swelling, redness and heat to my Left upper extremity along with swelling of lymph nodes and breast to the left side. with extreme tenderness. My physician currently has me a Medrol dose pack to help with the pain to my arms, hands and feet. So far no changes.  The stiffness and headaches have slightly improved.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Pain in extremity, Paraesthesia, Peripheral swelling, Pyrexia
Clinical narrative: Immediately that night I started having full nerve pain head to toe, not typical body aches. My lips went numb, I lost sensation in my hands and feet then it turned to pins and needles. Approx. 3 days after receiving the vaccination, it felt like I was walking on glass and my hands and feet would turn cyanotic off and on. Headaches and stiff neck. I ran fever for a week off and on, swelling, redness and heat to my Left upper extremity along with swelling of lymph nodes and breast to the left side. with extreme tenderness. My physician currently has me a Medrol dose pack to help with the pain to my arms, hands and feet. So far no changes.  The stiffness and headaches have slightly improved.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Sensory loss, Skin warm
Clinical narrative: Immediately that night I started having full nerve pain head to toe, not typical body aches. My lips went numb, I lost sensation in my hands and feet then it turned to pins and needles. Approx. 3 days after receiving the vaccination, it felt like I was walking on glass and my hands and feet would turn cyanotic off and on. Headaches and stiff neck. I ran fever for a week off and on, swelling, redness and heat to my Left upper extremity along with swelling of lymph nodes and breast to the left side. with extreme tenderness. My physician currently has me a Medrol dose pack to help with the pain to my arms, hands and feet. So far no changes.  The stiffness and headaches have slightly improved.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Patient died several hours after receiving first COVID-19 vaccine from Pfizer.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Anal incontinence, Clostridium test, Colitis, Colonoscopy abnormal, Culture stool
Clinical narrative: On March 18th I had a sudden onset of diarrhea/incontinence. I had no other symptoms.  I put myself on clear liquids. symptoms improved, then resumed with hematochezia and mucous. I took Loperamide with intermittent relief. This continued throughout March and into June. I lost weight. I contacted my PCP. I took Lomotil; this was effective. I was on a limited diet. I had a colonoscopy in August, 2021 which showed some mild inflammation in the lower colon. Diet changes do not resolve the situation. There was n o bleeding noted.  The symptoms continue.  am now on Budesimide.  Symptoms improved but not normal bowel function as yet.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Full blood count normal, Functional gastrointestinal disorder, Haematochezia, Metabolic function test
Clinical narrative: On March 18th I had a sudden onset of diarrhea/incontinence. I had no other symptoms.  I put myself on clear liquids. symptoms improved, then resumed with hematochezia and mucous. I took Loperamide with intermittent relief. This continued throughout March and into June. I lost weight. I contacted my PCP. I took Lomotil; this was effective. I was on a limited diet. I had a colonoscopy in August, 2021 which showed some mild inflammation in the lower colon. Diet changes do not resolve the situation. There was n o bleeding noted.  The symptoms continue.  am now on Budesimide.  Symptoms improved but not normal bowel function as yet.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: On March 18th I had a sudden onset of diarrhea/incontinence. I had no other symptoms.  I put myself on clear liquids. symptoms improved, then resumed with hematochezia and mucous. I took Loperamide with intermittent relief. This continued throughout March and into June. I lost weight. I contacted my PCP. I took Lomotil; this was effective. I was on a limited diet. I had a colonoscopy in August, 2021 which showed some mild inflammation in the lower colon. Diet changes do not resolve the situation. There was n o bleeding noted.  The symptoms continue.  am now on Budesimide.  Symptoms improved but not normal bowel function as yet.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Bladder catheter permanent, Blood creatinine increased, Blood glucose increased, COVID-19
Clinical narrative: Hospitalized (10.18.21);  COVID-19 positive (10.17.21);  fully vaccinated  Admission Date: 10/18/2021 Discharge Date: Oct 23, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus HOSPITAL COURSE: Patient is a 41 y/o man with past medical history significant for diabetes, CKD stage 5, hypertension and dyslipidemia presented to emergency department for shortness of breath. He presented to emergency department noted to have fever of 38.4, required non-rebreather and high-flow nasal cannula, creatinine of 7.5 under tested positive for COVID 19. For further evaluation by Nephrology patient was transferred to Hospital. On admission dexamethasone was started and Nephrology was consulted.  Nephrology evaluated patient and recommended PermCath. IR was consulted and PermCath was placed on 10/20. Dialysis was started on 10/20/2021 and continue daily for 3 days.  He was able to wean off of oxygen.  Due to high blood glucose levels while on dexamethasone Lantus dose is increased to 15 units at bedtime and started on sliding scale low-dose insulin. In stable condition patient is discharged home.
Age: 41.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Dialysis, Dyspnoea, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Hospitalized (10.18.21);  COVID-19 positive (10.17.21);  fully vaccinated  Admission Date: 10/18/2021 Discharge Date: Oct 23, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus HOSPITAL COURSE: Patient is a 41 y/o man with past medical history significant for diabetes, CKD stage 5, hypertension and dyslipidemia presented to emergency department for shortness of breath. He presented to emergency department noted to have fever of 38.4, required non-rebreather and high-flow nasal cannula, creatinine of 7.5 under tested positive for COVID 19. For further evaluation by Nephrology patient was transferred to Hospital. On admission dexamethasone was started and Nephrology was consulted.  Nephrology evaluated patient and recommended PermCath. IR was consulted and PermCath was placed on 10/20. Dialysis was started on 10/20/2021 and continue daily for 3 days.  He was able to wean off of oxygen.  Due to high blood glucose levels while on dexamethasone Lantus dose is increased to 15 units at bedtime and started on sliding scale low-dose insulin. In stable condition patient is discharged home.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint range of motion decreased, Mobility decreased, Neurological examination normal
Clinical narrative: Movement of left leg disturbed
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient administered dose of vaccine that had been in the refrigerator longer than 6 hours, which is the longest per manufacturer guidelines.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Cytomegalovirus test negative, Erythema, Fatigue, Laboratory test normal, Mononucleosis heterophile test negative
Clinical narrative: About 40 mins after the first dose, I started itching all over my chest up my neck to my nose. Both cheeks of my face were very red and warm-to-touch. Severe fatigue immediately hit me. By the morning when I woke up, I had throat swelling with bumps all over the back of my tongue that almost looked like raised blisters. Throat felt irritated like it was swollen.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Parvovirus B19 test negative, Pharyngeal swelling, Pruritus, SARS-CoV-2 antibody test, Skin warm
Clinical narrative: About 40 mins after the first dose, I started itching all over my chest up my neck to my nose. Both cheeks of my face were very red and warm-to-touch. Severe fatigue immediately hit me. By the morning when I woke up, I had throat swelling with bumps all over the back of my tongue that almost looked like raised blisters. Throat felt irritated like it was swollen.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Streptococcus test negative, Throat irritation, Tongue disorder
Clinical narrative: About 40 mins after the first dose, I started itching all over my chest up my neck to my nose. Both cheeks of my face were very red and warm-to-touch. Severe fatigue immediately hit me. By the morning when I woke up, I had throat swelling with bumps all over the back of my tongue that almost looked like raised blisters. Throat felt irritated like it was swollen.
Age: 73.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Blood test, Cardiac failure congestive, Chest X-ray, Computerised tomogram, Echocardiogram
Clinical narrative: Burning in muscles, complete fatigue, nightly fevers, excessive mucus, numbness in the feet, lost 28 pounds and lost all muscle.  Saw Dr., who sent him to an infectious disease doctor, a cardiologist, a pulminologist, an ENT, a rheumatologist.  Diagnosis is PMR, Giant Cell Arteritus, congestive heart failure, also increased pressures in eyes.  Waiting for approval to see a neurologist to confirm neuropathy in his feet.  Currently taking prednisone for the PMR and GCA, 2 heart meds- Entresto and Carvedilol, and a 3rd eye drop.  Dr is slowing weaning him off prednisone but expect him to be taking it thru July 2022.
Age: 73.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Fatigue, Giant cell arteritis, Hypoaesthesia, Myalgia, Neuropathy peripheral
Clinical narrative: Burning in muscles, complete fatigue, nightly fevers, excessive mucus, numbness in the feet, lost 28 pounds and lost all muscle.  Saw Dr., who sent him to an infectious disease doctor, a cardiologist, a pulminologist, an ENT, a rheumatologist.  Diagnosis is PMR, Giant Cell Arteritus, congestive heart failure, also increased pressures in eyes.  Waiting for approval to see a neurologist to confirm neuropathy in his feet.  Currently taking prednisone for the PMR and GCA, 2 heart meds- Entresto and Carvedilol, and a 3rd eye drop.  Dr is slowing weaning him off prednisone but expect him to be taking it thru July 2022.
Age: 73.0
Sex: M
Vaccine: COVID19, UNK
Symptoms: Ocular discomfort, Polymyalgia rheumatica, Pyrexia, Secretion discharge, Weight decreased
Clinical narrative: Burning in muscles, complete fatigue, nightly fevers, excessive mucus, numbness in the feet, lost 28 pounds and lost all muscle.  Saw Dr., who sent him to an infectious disease doctor, a cardiologist, a pulminologist, an ENT, a rheumatologist.  Diagnosis is PMR, Giant Cell Arteritus, congestive heart failure, also increased pressures in eyes.  Waiting for approval to see a neurologist to confirm neuropathy in his feet.  Currently taking prednisone for the PMR and GCA, 2 heart meds- Entresto and Carvedilol, and a 3rd eye drop.  Dr is slowing weaning him off prednisone but expect him to be taking it thru July 2022.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: 3rd dose given to under 18yo
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Hyperhidrosis, Immediate post-injection reaction, Injection site discomfort
Clinical narrative: I felt almost instant pain and pressure in my arm arm as soon as vaccine was administered, which was instantly followed by  dizziness, nausea and lightheadedness that built and built until about two minutes after the vaccine when I passed out. My girlfriend who was next to me caught me before I fell and I was in a chair so was uninjured from passing out, however, I was told by m girlfriend that the store workers were extremely slow to react and do anything to help. When I woke about 30 seconds later I felt much better, however, was still extremely dizzy, lightheaded and nauseous for the rest of the day and it didn?t really go away for the next 3 days at which point I still didn?t feel fully right but we?ll enough to go out. The night after the vaccine I was in agony all over my body and was sweating abnormal amounts throughout the night, these aches and pains also lasted for about 3 days. In short, it was probably the most sick I had felt in as long as I can remember.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Loss of consciousness, Nausea, Pain
Clinical narrative: I felt almost instant pain and pressure in my arm arm as soon as vaccine was administered, which was instantly followed by  dizziness, nausea and lightheadedness that built and built until about two minutes after the vaccine when I passed out. My girlfriend who was next to me caught me before I fell and I was in a chair so was uninjured from passing out, however, I was told by m girlfriend that the store workers were extremely slow to react and do anything to help. When I woke about 30 seconds later I felt much better, however, was still extremely dizzy, lightheaded and nauseous for the rest of the day and it didn?t really go away for the next 3 days at which point I still didn?t feel fully right but we?ll enough to go out. The night after the vaccine I was in agony all over my body and was sweating abnormal amounts throughout the night, these aches and pains also lasted for about 3 days. In short, it was probably the most sick I had felt in as long as I can remember.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Intermenstrual bleeding, Menstrual disorder
Clinical narrative: Menstruation disruption, a little heavier bleeding during periods  and spotting once or twice in between periods. This has been going on for about 3 months after receiving 2nd dose of Moderna  on 07/17/2021. I never use to spot between periods and now when I received the moderna vaccine, I have been. Also, after receiving my 2nd dose- the first month I had 2 periods and that has never happened in the past. It has been a little over 3 months & I continue to spot randomly in between periods & it just happens randomly that I?ll start bleeding.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heavy menstrual bleeding, Intermenstrual bleeding, Menstrual disorder, Polymenorrhoea
Clinical narrative: Menstruation disruption, a little heavier bleeding during periods  and spotting once or twice in between periods. This has been going on for about 3 months after receiving 2nd dose of Moderna  on 07/17/2021. I never use to spot between periods and now when I received the moderna vaccine, I have been. Also, after receiving my 2nd dose- the first month I had 2 periods and that has never happened in the past. It has been a little over 3 months & I continue to spot randomly in between periods & it just happens randomly that I?ll start bleeding.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Bloody discharge, Postmenopausal haemorrhage
Clinical narrative: Post menopausal bleeding.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Chills, Decreased appetite, Diarrhoea, Fatigue
Clinical narrative: Headache and fatigue immediately following shot. Starting 11 days later, diarrhea, nausea, loss of appetite, photosensitivity, fevers, body aches, chills, extreme fatigue, continued headaches, abdominal pain. These symptoms and fevers continued for 18 days,. Treated for presumed Lyme disease with 6 weeks Doxy.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Immediate post-injection reaction, Laboratory test, Nausea, Pain
Clinical narrative: Headache and fatigue immediately following shot. Starting 11 days later, diarrhea, nausea, loss of appetite, photosensitivity, fevers, body aches, chills, extreme fatigue, continued headaches, abdominal pain. These symptoms and fevers continued for 18 days,. Treated for presumed Lyme disease with 6 weeks Doxy.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Photosensitivity reaction, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Headache and fatigue immediately following shot. Starting 11 days later, diarrhea, nausea, loss of appetite, photosensitivity, fevers, body aches, chills, extreme fatigue, continued headaches, abdominal pain. These symptoms and fevers continued for 18 days,. Treated for presumed Lyme disease with 6 weeks Doxy.
Age: 56.0
Sex: F
Vaccine: FLUR4
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: From injection site to right elbow, from anterior to posterior arm was red, hot swollen, painful, burning for two days on day three it started to resolve with the application of warm soaks. Saw the Workers Comp doctor and my PCP.
Age: 77.0
Sex: F
Vaccine: FLU4
Symptoms: Extra dose administered
Clinical narrative: Patient denied having received flu vaccine for the 2021 flu season. Believed 10-05-21 Flu shot was an error. Immunization History Report. After receiving High-Dose Flu shot at Covid Clinic this day, the patient reported that she had received a flu shot at Clinic on 10-05-21 as recorded.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chronic obstructive pulmonary disease
Clinical narrative: Hospitalized (10.19.21 - current);  COVID-19 positive (10.17.21);  Fully vaccinated  Chief complaint Shortness of breath History of Present Illness:  Patient is a 61 y.o. male with a PMH including diabetes, COPD, T2DM, hypertension, obesity who presents for a 6 day history of worsening shortness of breath.  He reports that symptoms started approximately last Thursday and have consisted of shortness of breath, cough productive of clear sputum, decreased appetite. He reports he was unable to ambulate very short distances without getting winded. He is not on oxygen at baseline. Additionally, he notes that his eyes have been burning, with some yellow discharge which has improved.  He also endorses intermittent headaches since symptom onset.    He was previously seen in the emergency department yesterday as well as the day before and diagnosed with COVID-19 on 10/17/2021.  With these previous visits he was given Decadron 6 mg oral.  He also got a nebulizer and tried to use this for his breathing, but reports that his oxygen was still in the mid 80s.  He reports he is vaccinated against COVID-19, his wife was also recently diagnosed.  On presentation to the emergency department, patient arrived hypoxic at 84% on room air, tachycardic, afebrile.  He was placed on 6 L nasal cannula.  Patient given dose of Decadron and Remsevere.  He is admitted for further management of COVID-19 pneumonia. Progress Note from 10.26.21 (still admitted):  Subjective LOS: 7;  Patient seen lying on left side in bed.  States his breathing is about the same as yesterday but he does note that change from the high-flow nasal cannula to the intermediate flow nasal cannula.  He said this current setup is much more comfortable and easy to sleep.  He does not feel significantly short of breath with oxygen in place at rest but does continue to note dyspnea with ambulation.  Denies any additional symptoms such as chest pain, belly pain, nausea, vomiting. Assessment/Plan COVID 19 Pneumonia Acute Hypoxic Respiratory Failure  Oxygen requirement decreasing very slowly, still short of breath with minimal exertion Presenting symptoms: Shortness of breath, cough Vaccinated COVID 19 detected by PCR: 10/17/21. CXR with findings of streaky basilar airspace disease on 10/18/21. Current oxygen requirement 60% FiO2 HFNC Severe Respiratory isolation Dexamethasone 6 mg oral daily (day 10/10) Completed 5 day course of remdesivir  10/23 Daily labs CBC with differential, CMP, D-dimer  Tessalon pearls Monitor I/O Continuous pulse oximetry  Recommend proning VTE prophylaxis with Lovenox Renal function stable, continue IV Lasix 20mg daily COPD Acute exacerbation of COPD, now resolved Initially with acute exacerbation given increased SOB and sputum production.  - s/p azithromycin 500mg x 3d - Albuterol, dulera ordered
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Decreased appetite, Differential white blood cell count, Dyspnoea, Dyspnoea exertional
Clinical narrative: Hospitalized (10.19.21 - current);  COVID-19 positive (10.17.21);  Fully vaccinated  Chief complaint Shortness of breath History of Present Illness:  Patient is a 61 y.o. male with a PMH including diabetes, COPD, T2DM, hypertension, obesity who presents for a 6 day history of worsening shortness of breath.  He reports that symptoms started approximately last Thursday and have consisted of shortness of breath, cough productive of clear sputum, decreased appetite. He reports he was unable to ambulate very short distances without getting winded. He is not on oxygen at baseline. Additionally, he notes that his eyes have been burning, with some yellow discharge which has improved.  He also endorses intermittent headaches since symptom onset.    He was previously seen in the emergency department yesterday as well as the day before and diagnosed with COVID-19 on 10/17/2021.  With these previous visits he was given Decadron 6 mg oral.  He also got a nebulizer and tried to use this for his breathing, but reports that his oxygen was still in the mid 80s.  He reports he is vaccinated against COVID-19, his wife was also recently diagnosed.  On presentation to the emergency department, patient arrived hypoxic at 84% on room air, tachycardic, afebrile.  He was placed on 6 L nasal cannula.  Patient given dose of Decadron and Remsevere.  He is admitted for further management of COVID-19 pneumonia. Progress Note from 10.26.21 (still admitted):  Subjective LOS: 7;  Patient seen lying on left side in bed.  States his breathing is about the same as yesterday but he does note that change from the high-flow nasal cannula to the intermediate flow nasal cannula.  He said this current setup is much more comfortable and easy to sleep.  He does not feel significantly short of breath with oxygen in place at rest but does continue to note dyspnea with ambulation.  Denies any additional symptoms such as chest pain, belly pain, nausea, vomiting. Assessment/Plan COVID 19 Pneumonia Acute Hypoxic Respiratory Failure  Oxygen requirement decreasing very slowly, still short of breath with minimal exertion Presenting symptoms: Shortness of breath, cough Vaccinated COVID 19 detected by PCR: 10/17/21. CXR with findings of streaky basilar airspace disease on 10/18/21. Current oxygen requirement 60% FiO2 HFNC Severe Respiratory isolation Dexamethasone 6 mg oral daily (day 10/10) Completed 5 day course of remdesivir  10/23 Daily labs CBC with differential, CMP, D-dimer  Tessalon pearls Monitor I/O Continuous pulse oximetry  Recommend proning VTE prophylaxis with Lovenox Renal function stable, continue IV Lasix 20mg daily COPD Acute exacerbation of COPD, now resolved Initially with acute exacerbation given increased SOB and sputum production.  - s/p azithromycin 500mg x 3d - Albuterol, dulera ordered